nivolumab,zolbetuximab
bms,astellas
[]
nivo or zolbetuximab? is claudin 18.2 is a marker for better prognosis? intresting data. options for 1st line metastatic gastric and ge junction increasing. #ascogi23 #gi23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists